aluates Reports

$ 0.0

Automative

Global Retinitis Pigmentosa Treatment Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-25P6040

Global Retinitis Pigmentosa Treatment Market Insights Forecast to 2028

BUY CHAPTERS

Global Retinitis Pigmentosa Treatment Market Research Report 2024

Code: QYRE-Auto-25P6040

Report

August 2024

Pages:99

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astellas Pharma Inc

Caladrius Biosciences Inc

Dompe Farmaceutici

Genable Technologies Limited

Genethon

GenSight Biologics S.A.

Grupo Ferrer Internacional, S.A.

ID Pharma Co Ltd

InFlectis BioScience

International Stem Cell Corporation

Ionis Pharmaceuticals Inc

M's Science Corporation

Mimetogen Pharmaceuticals Inc.

Nanovector s.r.l.

Orphagen Pharmaceuticals, Inc.

Retinitis Pigmentosa Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Retinitis Pigmentosa Treatment Market

The global Retinitis Pigmentosa Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Retinitis Pigmentosa Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retinitis Pigmentosa Treatment.

Report Scope

The Retinitis Pigmentosa Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Retinitis Pigmentosa Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Retinitis Pigmentosa Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Retinitis Pigmentosa Treatment Market Report

Report Metric	Details
Report Name	Retinitis Pigmentosa Treatment Market
CAGR	5%
Segment by Type	BNP-RP Cenegermin CPK-850 Cutamesine FAB-111 Others
Segment by Application	Hospital Clinic Homecare
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Astellas Pharma Inc., Caladrius Biosciences, Inc., Dompe Farmaceutici S.p.A., Genable Technologies Limited, Genethon, GenSight Biologics S.A., Grupo Ferrer Internacional, S.A., ID Pharma Co., Ltd., InFlectis BioScience, International Stem Cell Corporation, Ionis Pharmaceuticals, Inc., M's Science Corporation, Mimetogen Pharmaceuticals Inc., Nanovector s.r.l., Orphagen Pharmaceuticals, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Retinitis Pigmentosa Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Retinitis Pigmentosa Treatment Market report?

Ans: The main players in the Retinitis Pigmentosa Treatment Market are Astellas Pharma Inc., Caladrius Biosciences, Inc., Dompe Farmaceutici S.p.A., Genable Technologies Limited, Genethon, GenSight Biologics S.A., Grupo Ferrer Internacional, S.A., ID Pharma Co., Ltd., InFlectis BioScience, International Stem Cell Corporation, Ionis Pharmaceuticals, Inc., M's Science Corporation, Mimetogen Pharmaceuticals Inc., Nanovector s.r.l., Orphagen Pharmaceuticals, Inc.

What are the Application segmentation covered in the Retinitis Pigmentosa Treatment Market report?

Ans: The Applications covered in the Retinitis Pigmentosa Treatment Market report are Hospital, Clinic, Homecare

What are the Type segmentation covered in the Retinitis Pigmentosa Treatment Market report?

Ans: The Types covered in the Retinitis Pigmentosa Treatment Market report are BNP-RP, Cenegermin, CPK-850, Cutamesine, FAB-111, Others

Recommended Reports

Ophthalmic Diseases

Ocular Treatments

Genetic & Rare Diseases

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Retinitis Pigmentosa Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 BNP-RP

1.2.3 Cenegermin

1.2.4 CPK-850

1.2.5 Cutamesine

1.2.6 FAB-111

1.2.7 Others

1.3 Market by Application

1.3.1 Global Retinitis Pigmentosa Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Homecare

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Retinitis Pigmentosa Treatment Market Perspective (2019-2030)

2.2 Retinitis Pigmentosa Treatment Growth Trends by Region

2.2.1 Global Retinitis Pigmentosa Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Retinitis Pigmentosa Treatment Historic Market Size by Region (2019-2024)

2.2.3 Retinitis Pigmentosa Treatment Forecasted Market Size by Region (2025-2030)

2.3 Retinitis Pigmentosa Treatment Market Dynamics

2.3.1 Retinitis Pigmentosa Treatment Industry Trends

2.3.2 Retinitis Pigmentosa Treatment Market Drivers

2.3.3 Retinitis Pigmentosa Treatment Market Challenges

2.3.4 Retinitis Pigmentosa Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Retinitis Pigmentosa Treatment Players by Revenue

3.1.1 Global Top Retinitis Pigmentosa Treatment Players by Revenue (2019-2024)

3.1.2 Global Retinitis Pigmentosa Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Retinitis Pigmentosa Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Retinitis Pigmentosa Treatment Revenue

3.4 Global Retinitis Pigmentosa Treatment Market Concentration Ratio

3.4.1 Global Retinitis Pigmentosa Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Retinitis Pigmentosa Treatment Revenue in 2023

3.5 Retinitis Pigmentosa Treatment Key Players Head office and Area Served

3.6 Key Players Retinitis Pigmentosa Treatment Product Solution and Service

3.7 Date of Enter into Retinitis Pigmentosa Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Retinitis Pigmentosa Treatment Breakdown Data by Type

4.1 Global Retinitis Pigmentosa Treatment Historic Market Size by Type (2019-2024)

4.2 Global Retinitis Pigmentosa Treatment Forecasted Market Size by Type (2025-2030)

5 Retinitis Pigmentosa Treatment Breakdown Data by Application

5.1 Global Retinitis Pigmentosa Treatment Historic Market Size by Application (2019-2024)

5.2 Global Retinitis Pigmentosa Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Retinitis Pigmentosa Treatment Market Size (2019-2030)

6.2 North America Retinitis Pigmentosa Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Retinitis Pigmentosa Treatment Market Size by Country (2019-2024)

6.4 North America Retinitis Pigmentosa Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Retinitis Pigmentosa Treatment Market Size (2019-2030)

7.2 Europe Retinitis Pigmentosa Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Retinitis Pigmentosa Treatment Market Size by Country (2019-2024)

7.4 Europe Retinitis Pigmentosa Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Retinitis Pigmentosa Treatment Market Size (2019-2030)

8.2 Asia-Pacific Retinitis Pigmentosa Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Retinitis Pigmentosa Treatment Market Size (2019-2030)

9.2 Latin America Retinitis Pigmentosa Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Retinitis Pigmentosa Treatment Market Size by Country (2019-2024)

9.4 Latin America Retinitis Pigmentosa Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Retinitis Pigmentosa Treatment Market Size (2019-2030)

10.2 Middle East & Africa Retinitis Pigmentosa Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Astellas Pharma Inc.

11.1.1 Astellas Pharma Inc. Company Detail

11.1.2 Astellas Pharma Inc. Business Overview

11.1.3 Astellas Pharma Inc. Retinitis Pigmentosa Treatment Introduction

11.1.4 Astellas Pharma Inc. Revenue in Retinitis Pigmentosa Treatment Business (2019-2024)

11.1.5 Astellas Pharma Inc. Recent Development

11.2 Caladrius Biosciences, Inc.

11.2.1 Caladrius Biosciences, Inc. Company Detail

11.2.2 Caladrius Biosciences, Inc. Business Overview

11.2.3 Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Introduction

11.2.4 Caladrius Biosciences, Inc. Revenue in Retinitis Pigmentosa Treatment Business (2019-2024)

11.2.5 Caladrius Biosciences, Inc. Recent Development

11.3 Dompe Farmaceutici S.p.A.

11.3.1 Dompe Farmaceutici S.p.A. Company Detail

11.3.2 Dompe Farmaceutici S.p.A. Business Overview

11.3.3 Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Introduction

11.3.4 Dompe Farmaceutici S.p.A. Revenue in Retinitis Pigmentosa Treatment Business (2019-2024)

11.3.5 Dompe Farmaceutici S.p.A. Recent Development

11.4 Genable Technologies Limited

11.4.1 Genable Technologies Limited Company Detail

11.4.2 Genable Technologies Limited Business Overview

11.4.3 Genable Technologies Limited Retinitis Pigmentosa Treatment Introduction

11.4.4 Genable Technologies Limited Revenue in Retinitis Pigmentosa Treatment Business (2019-2024)

11.4.5 Genable Technologies Limited Recent Development

11.5 Genethon

11.5.1 Genethon Company Detail

11.5.2 Genethon Business Overview

11.5.3 Genethon Retinitis Pigmentosa Treatment Introduction

11.5.4 Genethon Revenue in Retinitis Pigmentosa Treatment Business (2019-2024)

11.5.5 Genethon Recent Development

11.6 GenSight Biologics S.A.

11.6.1 GenSight Biologics S.A. Company Detail

11.6.2 GenSight Biologics S.A. Business Overview

11.6.3 GenSight Biologics S.A. Retinitis Pigmentosa Treatment Introduction

11.6.4 GenSight Biologics S.A. Revenue in Retinitis Pigmentosa Treatment Business (2019-2024)

11.6.5 GenSight Biologics S.A. Recent Development

11.7 Grupo Ferrer Internacional, S.A.

11.7.1 Grupo Ferrer Internacional, S.A. Company Detail

11.7.2 Grupo Ferrer Internacional, S.A. Business Overview

11.7.3 Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Introduction

11.7.4 Grupo Ferrer Internacional, S.A. Revenue in Retinitis Pigmentosa Treatment Business (2019-2024)

11.7.5 Grupo Ferrer Internacional, S.A. Recent Development

11.8 ID Pharma Co., Ltd.

11.8.1 ID Pharma Co., Ltd. Company Detail

11.8.2 ID Pharma Co., Ltd. Business Overview

11.8.3 ID Pharma Co., Ltd. Retinitis Pigmentosa Treatment Introduction

11.8.4 ID Pharma Co., Ltd. Revenue in Retinitis Pigmentosa Treatment Business (2019-2024)

11.8.5 ID Pharma Co., Ltd. Recent Development

11.9 InFlectis BioScience

11.9.1 InFlectis BioScience Company Detail

11.9.2 InFlectis BioScience Business Overview

11.9.3 InFlectis BioScience Retinitis Pigmentosa Treatment Introduction

11.9.4 InFlectis BioScience Revenue in Retinitis Pigmentosa Treatment Business (2019-2024)

11.9.5 InFlectis BioScience Recent Development

11.10 International Stem Cell Corporation

11.10.1 International Stem Cell Corporation Company Detail

11.10.2 International Stem Cell Corporation Business Overview

11.10.3 International Stem Cell Corporation Retinitis Pigmentosa Treatment Introduction

11.10.4 International Stem Cell Corporation Revenue in Retinitis Pigmentosa Treatment Business (2019-2024)

11.10.5 International Stem Cell Corporation Recent Development

11.11 Ionis Pharmaceuticals, Inc.

11.11.1 Ionis Pharmaceuticals, Inc. Company Detail

11.11.2 Ionis Pharmaceuticals, Inc. Business Overview

11.11.3 Ionis Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Introduction

11.11.4 Ionis Pharmaceuticals, Inc. Revenue in Retinitis Pigmentosa Treatment Business (2019-2024)

11.11.5 Ionis Pharmaceuticals, Inc. Recent Development

11.12 M's Science Corporation

11.12.1 M's Science Corporation Company Detail

11.12.2 M's Science Corporation Business Overview

11.12.3 M's Science Corporation Retinitis Pigmentosa Treatment Introduction

11.12.4 M's Science Corporation Revenue in Retinitis Pigmentosa Treatment Business (2019-2024)

11.12.5 M's Science Corporation Recent Development

11.13 Mimetogen Pharmaceuticals Inc.

11.13.1 Mimetogen Pharmaceuticals Inc. Company Detail

11.13.2 Mimetogen Pharmaceuticals Inc. Business Overview

11.13.3 Mimetogen Pharmaceuticals Inc. Retinitis Pigmentosa Treatment Introduction

11.13.4 Mimetogen Pharmaceuticals Inc. Revenue in Retinitis Pigmentosa Treatment Business (2019-2024)

11.13.5 Mimetogen Pharmaceuticals Inc. Recent Development

11.14 Nanovector s.r.l.

11.14.1 Nanovector s.r.l. Company Detail

11.14.2 Nanovector s.r.l. Business Overview

11.14.3 Nanovector s.r.l. Retinitis Pigmentosa Treatment Introduction

11.14.4 Nanovector s.r.l. Revenue in Retinitis Pigmentosa Treatment Business (2019-2024)

11.14.5 Nanovector s.r.l. Recent Development

11.15 Orphagen Pharmaceuticals, Inc.

11.15.1 Orphagen Pharmaceuticals, Inc. Company Detail

11.15.2 Orphagen Pharmaceuticals, Inc. Business Overview

11.15.3 Orphagen Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Introduction

11.15.4 Orphagen Pharmaceuticals, Inc. Revenue in Retinitis Pigmentosa Treatment Business (2019-2024)

11.15.5 Orphagen Pharmaceuticals, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Astellas Pharma Inc

Caladrius Biosciences Inc

Dompe Farmaceutici

Genable Technologies Limited

Genethon

GenSight Biologics S.A.

Grupo Ferrer Internacional, S.A.

ID Pharma Co Ltd

InFlectis BioScience

International Stem Cell Corporation

Ionis Pharmaceuticals Inc

M's Science Corporation

Mimetogen Pharmaceuticals Inc.

Nanovector s.r.l.

Orphagen Pharmaceuticals, Inc.

List of Tables

Table 1. Global Retinitis Pigmentosa Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of BNP-RP

Table 3. Key Players of Cenegermin

Table 4. Key Players of CPK-850

Table 5. Key Players of Cutamesine

Table 6. Key Players of FAB-111

Table 7. Key Players of Others

Table 8. Global Retinitis Pigmentosa Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Retinitis Pigmentosa Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Retinitis Pigmentosa Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Retinitis Pigmentosa Treatment Market Share by Region (2019-2024)

Table 12. Global Retinitis Pigmentosa Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Retinitis Pigmentosa Treatment Market Share by Region (2025-2030)

Table 14. Retinitis Pigmentosa Treatment Market Trends

Table 15. Retinitis Pigmentosa Treatment Market Drivers

Table 16. Retinitis Pigmentosa Treatment Market Challenges

Table 17. Retinitis Pigmentosa Treatment Market Restraints

Table 18. Global Retinitis Pigmentosa Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Retinitis Pigmentosa Treatment Market Share by Players (2019-2024)

Table 20. Global Top Retinitis Pigmentosa Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinitis Pigmentosa Treatment as of 2023)

Table 21. Ranking of Global Top Retinitis Pigmentosa Treatment Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Retinitis Pigmentosa Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Retinitis Pigmentosa Treatment Product Solution and Service

Table 25. Date of Enter into Retinitis Pigmentosa Treatment Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Retinitis Pigmentosa Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Retinitis Pigmentosa Treatment Revenue Market Share by Type (2019-2024)

Table 29. Global Retinitis Pigmentosa Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Retinitis Pigmentosa Treatment Revenue Market Share by Type (2025-2030)

Table 31. Global Retinitis Pigmentosa Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Retinitis Pigmentosa Treatment Revenue Market Share by Application (2019-2024)

Table 33. Global Retinitis Pigmentosa Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Retinitis Pigmentosa Treatment Revenue Market Share by Application (2025-2030)

Table 35. North America Retinitis Pigmentosa Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Retinitis Pigmentosa Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Retinitis Pigmentosa Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Retinitis Pigmentosa Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Retinitis Pigmentosa Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Retinitis Pigmentosa Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Retinitis Pigmentosa Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Retinitis Pigmentosa Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Retinitis Pigmentosa Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Retinitis Pigmentosa Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Retinitis Pigmentosa Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 50. Astellas Pharma Inc. Company Detail

Table 51. Astellas Pharma Inc. Business Overview

Table 52. Astellas Pharma Inc. Retinitis Pigmentosa Treatment Product

Table 53. Astellas Pharma Inc. Revenue in Retinitis Pigmentosa Treatment Business (2019-2024) & (US$ Million)

Table 54. Astellas Pharma Inc. Recent Development

Table 55. Caladrius Biosciences, Inc. Company Detail

Table 56. Caladrius Biosciences, Inc. Business Overview

Table 57. Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Product

Table 58. Caladrius Biosciences, Inc. Revenue in Retinitis Pigmentosa Treatment Business (2019-2024) & (US$ Million)

Table 59. Caladrius Biosciences, Inc. Recent Development

Table 60. Dompe Farmaceutici S.p.A. Company Detail

Table 61. Dompe Farmaceutici S.p.A. Business Overview

Table 62. Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Product

Table 63. Dompe Farmaceutici S.p.A. Revenue in Retinitis Pigmentosa Treatment Business (2019-2024) & (US$ Million)

Table 64. Dompe Farmaceutici S.p.A. Recent Development

Table 65. Genable Technologies Limited Company Detail

Table 66. Genable Technologies Limited Business Overview

Table 67. Genable Technologies Limited Retinitis Pigmentosa Treatment Product

Table 68. Genable Technologies Limited Revenue in Retinitis Pigmentosa Treatment Business (2019-2024) & (US$ Million)

Table 69. Genable Technologies Limited Recent Development

Table 70. Genethon Company Detail

Table 71. Genethon Business Overview

Table 72. Genethon Retinitis Pigmentosa Treatment Product

Table 73. Genethon Revenue in Retinitis Pigmentosa Treatment Business (2019-2024) & (US$ Million)

Table 74. Genethon Recent Development

Table 75. GenSight Biologics S.A. Company Detail

Table 76. GenSight Biologics S.A. Business Overview

Table 77. GenSight Biologics S.A. Retinitis Pigmentosa Treatment Product

Table 78. GenSight Biologics S.A. Revenue in Retinitis Pigmentosa Treatment Business (2019-2024) & (US$ Million)

Table 79. GenSight Biologics S.A. Recent Development

Table 80. Grupo Ferrer Internacional, S.A. Company Detail

Table 81. Grupo Ferrer Internacional, S.A. Business Overview

Table 82. Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Product

Table 83. Grupo Ferrer Internacional, S.A. Revenue in Retinitis Pigmentosa Treatment Business (2019-2024) & (US$ Million)

Table 84. Grupo Ferrer Internacional, S.A. Recent Development

Table 85. ID Pharma Co., Ltd. Company Detail

Table 86. ID Pharma Co., Ltd. Business Overview

Table 87. ID Pharma Co., Ltd. Retinitis Pigmentosa Treatment Product

Table 88. ID Pharma Co., Ltd. Revenue in Retinitis Pigmentosa Treatment Business (2019-2024) & (US$ Million)

Table 89. ID Pharma Co., Ltd. Recent Development

Table 90. InFlectis BioScience Company Detail

Table 91. InFlectis BioScience Business Overview

Table 92. InFlectis BioScience Retinitis Pigmentosa Treatment Product

Table 93. InFlectis BioScience Revenue in Retinitis Pigmentosa Treatment Business (2019-2024) & (US$ Million)

Table 94. InFlectis BioScience Recent Development

Table 95. International Stem Cell Corporation Company Detail

Table 96. International Stem Cell Corporation Business Overview

Table 97. International Stem Cell Corporation Retinitis Pigmentosa Treatment Product

Table 98. International Stem Cell Corporation Revenue in Retinitis Pigmentosa Treatment Business (2019-2024) & (US$ Million)

Table 99. International Stem Cell Corporation Recent Development

Table 100. Ionis Pharmaceuticals, Inc. Company Detail

Table 101. Ionis Pharmaceuticals, Inc. Business Overview

Table 102. Ionis Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Product

Table 103. Ionis Pharmaceuticals, Inc. Revenue in Retinitis Pigmentosa Treatment Business (2019-2024) & (US$ Million)

Table 104. Ionis Pharmaceuticals, Inc. Recent Development

Table 105. M's Science Corporation Company Detail

Table 106. M's Science Corporation Business Overview

Table 107. M's Science Corporation Retinitis Pigmentosa Treatment Product

Table 108. M's Science Corporation Revenue in Retinitis Pigmentosa Treatment Business (2019-2024) & (US$ Million)

Table 109. M's Science Corporation Recent Development

Table 110. Mimetogen Pharmaceuticals Inc. Company Detail

Table 111. Mimetogen Pharmaceuticals Inc. Business Overview

Table 112. Mimetogen Pharmaceuticals Inc. Retinitis Pigmentosa Treatment Product

Table 113. Mimetogen Pharmaceuticals Inc. Revenue in Retinitis Pigmentosa Treatment Business (2019-2024) & (US$ Million)

Table 114. Mimetogen Pharmaceuticals Inc. Recent Development

Table 115. Nanovector s.r.l. Company Detail

Table 116. Nanovector s.r.l. Business Overview

Table 117. Nanovector s.r.l. Retinitis Pigmentosa Treatment Product

Table 118. Nanovector s.r.l. Revenue in Retinitis Pigmentosa Treatment Business (2019-2024) & (US$ Million)

Table 119. Nanovector s.r.l. Recent Development

Table 120. Orphagen Pharmaceuticals, Inc. Company Detail

Table 121. Orphagen Pharmaceuticals, Inc. Business Overview

Table 122. Orphagen Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Product

Table 123. Orphagen Pharmaceuticals, Inc. Revenue in Retinitis Pigmentosa Treatment Business (2019-2024) & (US$ Million)

Table 124. Orphagen Pharmaceuticals, Inc. Recent Development

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Retinitis Pigmentosa Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Retinitis Pigmentosa Treatment Market Share by Type: 2023 VS 2030

Figure 3. BNP-RP Features

Figure 4. Cenegermin Features

Figure 5. CPK-850 Features

Figure 6. Cutamesine Features

Figure 7. FAB-111 Features

Figure 8. Others Features

Figure 9. Global Retinitis Pigmentosa Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Retinitis Pigmentosa Treatment Market Share by Application: 2023 VS 2030

Figure 11. Hospital Case Studies

Figure 12. Clinic Case Studies

Figure 13. Homecare Case Studies

Figure 14. Retinitis Pigmentosa Treatment Report Years Considered

Figure 15. Global Retinitis Pigmentosa Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Retinitis Pigmentosa Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Retinitis Pigmentosa Treatment Market Share by Region: 2023 VS 2030

Figure 18. Global Retinitis Pigmentosa Treatment Market Share by Players in 2023

Figure 19. Global Top Retinitis Pigmentosa Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinitis Pigmentosa Treatment as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Retinitis Pigmentosa Treatment Revenue in 2023

Figure 21. North America Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Retinitis Pigmentosa Treatment Market Share by Country (2019-2030)

Figure 23. United States Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Retinitis Pigmentosa Treatment Market Share by Country (2019-2030)

Figure 27. Germany Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Retinitis Pigmentosa Treatment Market Share by Region (2019-2030)

Figure 35. China Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Retinitis Pigmentosa Treatment Market Share by Country (2019-2030)

Figure 43. Mexico Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Retinitis Pigmentosa Treatment Market Share by Country (2019-2030)

Figure 47. Turkey Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Retinitis Pigmentosa Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Astellas Pharma Inc. Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2019-2024)

Figure 50. Caladrius Biosciences, Inc. Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2019-2024)

Figure 51. Dompe Farmaceutici S.p.A. Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2019-2024)

Figure 52. Genable Technologies Limited Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2019-2024)

Figure 53. Genethon Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2019-2024)

Figure 54. GenSight Biologics S.A. Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2019-2024)

Figure 55. Grupo Ferrer Internacional, S.A. Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2019-2024)

Figure 56. ID Pharma Co., Ltd. Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2019-2024)

Figure 57. InFlectis BioScience Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2019-2024)

Figure 58. International Stem Cell Corporation Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2019-2024)

Figure 59. Ionis Pharmaceuticals, Inc. Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2019-2024)

Figure 60. M's Science Corporation Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2019-2024)

Figure 61. Mimetogen Pharmaceuticals Inc. Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2019-2024)

Figure 62. Nanovector s.r.l. Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2019-2024)

Figure 63. Orphagen Pharmaceuticals, Inc. Revenue Growth Rate in Retinitis Pigmentosa Treatment Business (2019-2024)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Retinal Dystrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Retinal Disorder Treatment Market Research Report 2024

Global Skin Pigmentation Disorder Treatment Market Research Report 2024

Global Retinopathy Of Prematurity Therapeutics Market Research Report 2024

Global Posterior Segment Eye Disease Treatment Market Research Report 2024

Pigmentation Treatment Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Retinal Detachment Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmic Disease Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Optic Neuritis Drug Market Research Report 2025

Retinoid Treatment for Skin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Eye Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Proliferative Diabetic Retinopathy Therapeutics Market Research Report 2024

Global Juvenile Macular Degeneration Treatment Market Research Report 2024

Ophthalmic Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Diabetic Retinopathy Fundus Image assisted Diagnosis Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Amblyopia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vitiligo Drug Market Research Report 2024

Global Proliferative Vitreoretinopathy PVR Therapeutics Market Research Report 2024

Retinal Detachment Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions